Top Stories
-
New faculty who recently joined VP&S include hospitalists, a doctor at the new ColumbiaDoctors Lincoln Center location, and an emergency medicine doctor also board-certified in sports medicine.
Topic
-
People who donate their bodies to medical school anatomy courses provide an unparalleled training opportunity for future physicians.
Topic
-
Virginia Apgar, creator of the Apgar Score, made contributions beyond the score that has been used for seven decades to assess the health of newborns.
Topic
-
New faculty who joined VP&S in April and June include an emergency medicine doctor and a radiologist who has helped translate state-of-the-art imaging techniques.
Topic
Latest News
- July 14, 2014
The ability to diagnose Alzheimer’s before the onset of symptoms would allow physicians to treat it before extensive brain damage has occurred.
Topic
- July 11, 2014
In preclinical tests, a two-drug combination that blocks cancer’s escape route shows promise against MPNST, an aggressive nerve tumor.
Topic
- July 9, 2014
The new 2014 Irving Scholars are Siddhartha Mukherjee, Carolyn Rodriguez, Bret Rutherford, and Anne-Catrin Uhlemann.
Topic
- July 7, 2014
Columbia is part of a new consortium to identify rare genetic variants that may protect against, or contribute to Alzheimer’s disease.
Topic
- June 25, 2014
Several drugs in development for pancreatic cancer dissolve the dense tissue that surrounds and protects the tumors, but new research shows why some may not work.
Topic
- June 9, 2014
A new study measures the risk of developing Parkinson's for people with Gaucher disease and Gaucher carriers.
Topic
- June 3, 2014
The prize recognizes his groundbreaking work on the neural networks of the spinal cord involved in the control of movement.
Topic
- May 30, 2014
P&S systems biologists dive into huge databases of genomes, proteins, and metabolites to find new ways to target the world’s most deadly pathogens.
Topic
- May 22, 2014
The P&S 2014 graduation ceremony comes alive in pictures.
Topic
- May 22, 2014
In clinical trials, two new drugs slowed the loss of lung function in patients with a fatal lung disease, idiopathic pulmonary fibrosis.
Topic
